Longeveron shares Phase 2a laromestrocel data at AAIC 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. CMG
7. TENB
8. BIIB
9. KLAC
10. ETSY

Go back to Longeveron shares Phase 2a laromestrocel data at AAIC 2026

Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in P

July 13, 2026 7:05 AM EDT

Poster Presentation at the 2026 Alzheimers Association International Conference (AAIC) entitled Laromestrocel Stabilizes Brain Inflammation In Key Alzheimers Disease Gray And White Matter Regions As Assessed Using Free Water MRI presented at July 13th In Person Poster Presentation SessionResults support a clinically relevant and long-lasting anti-inflammatory mechanism of action of laromestrocel in gray and white matter of the brain, indicate potential blood biomarker correlates with clinical outcomes, and support continued clinical development of laromestrocel for Alzheimers diseaseLongeveron has... More